Samtidig administration kan resultere i kompetitiv hæmning af metabolismen af disse aktive stoffer.
29 Telzir must not be administered concurrently with medicinal products with narrow therapeutic windows containing active substances that are substrates of cytochrome P450 3A4 (CYP3A4).